bioMérieux, Inc. is a global company that makes lab tests and other in-vitro diagnostic products. Its filings show it lobbies Congress on health and budget issues, including preventing antimicrobial resistance, incentives to develop new antibiotics, changes to Medicare clinical laboratory payments, trade, and tax provisions like Section 899 of the U.S. Tax Code. It used the law firm Alston & Bird LLP to lobby.
Show the dominant industry call, how mixed the client looks, and the allocation across the top labeled sectors.
Annual totals based on disclosed filing amounts.
Issue rankings are based on disclosed activity mentions, with filing amounts apportioned evenly across issues within the same filing.
The lobbying registrants handling this client, ranked by disclosed filing amounts.
Lobbyists are ranked by appearances and an equal share of each filing's reported amount.
ALEXANDER GRAF
The latest disclosures for this client.
ALSTON & BIRD LLP
Q2ALSTON & BIRD LLP
Q1The entities named in disclosed activities are the clearest available signal for where the client is aiming attention.
ALSTON & BIRD LLP
JAMES PATRICK PALUSKIEWICZ
ALSTON & BIRD LLP
JONATHAN JAGODA
ALSTON & BIRD LLP
MARK RAYDER
ALSTON & BIRD LLP
ms JOYCE E GRESKO
ALSTON & BIRD LLP
MICHAEL PARK
ALSTON & BIRD LLP
JOSEPH BODDICKER
ALSTON & BIRD LLP
EVAN COLLIER
ALSTON & BIRD LLP
ALSTON & BIRD LLP
Q4ALSTON & BIRD LLP
Q3ALSTON & BIRD LLP
Q2ALSTON & BIRD LLP
RR